Open official notice

中新薬業 “ハイデラ and 22 other products” - Recall

Official notice

26 Nov 2021

Last checked

27 Oct 2026

RecallScope risk estimate:MediumCAA Japan

An official CAA Japan notice concerns 中新薬業 “ハイデラ and 22 other products” - Recall. Manufactured using quantities of additives different from those specified in the approval documents, and other issues. Reasons for recall: (1)ハイデラ, (2)マッハII, (4)オピス錠, (5)ヅシチン錠D, (8)赤玉ベリンはら薬: Because these products were manufactured using quantities of additives different from those specified in the approval documents, we have decided to voluntarily recall all lots manufactured using those quantities. (3)新ビターコルド, (9)ニューリキスカット: Because these products were manufactured using procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (6)新かぜキノミン: Because this product was manufactured using quantities of additives different from those specified in the approval documents and additives not listed in the approval documents, we have decided to voluntarily recall all lots. (7)聖心丸, (10)せき, (11)ネツトリトンプク, (12)ノイスルピー, (13)ブレーエン, (14)解熱鎮痛アスナオール, (15)チンツーサン: Because these products were manufactured using quantities of additives different from those specified in the approval documents and procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (16)アスパライトE40, (17)アイムードE40, (18)ニューハイアートE, (19)アスパライトロイヤルE: Stability monitoring results indicate that the possibility that the measured neostigmine methylsulfate content may fall outside the approved specifications within the shelf life (4 years 6 months or 4 years 1 month) cannot be ruled out. We have therefore decided to voluntarily recall all lots with a shelf life of 4 years 6 months or 4 years 1 month. Published 2021-11-26.

What to do now

Because these products are medicines supplied through a household placement service, we know all delivery destinations. We will notify them of the recall in writing and collect the products.

Recall number

2-10439

Official notice

2021-11-26

The hazard

Manufactured using quantities of additives different from those specified in the approval documents, and other issues. Reasons for recall: (1)ハイデラ, (2)マッハII, (4)オピス錠, (5)ヅシチン錠D, (8)赤玉ベリンはら薬: Because these products were manufactured using quantities of additives different from those specified in the approval documents, we have decided to voluntarily recall all lots manufactured using those quantities. (3)新ビターコルド, (9)ニューリキスカット: Because these products were manufactured using procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (6)新かぜキノミン: Because this product was manufactured using quantities of additives different from those specified in the approval documents and additives not listed in the approval documents, we have decided to voluntarily recall all lots. (7)聖心丸, (10)せき, (11)ネツトリトンプク, (12)ノイスルピー, (13)ブレーエン, (14)解熱鎮痛アスナオール, (15)チンツーサン: Because these products were manufactured using quantities of additives different from those specified in the approval documents and procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (16)アスパライトE40, (17)アイムードE40, (18)ニューハイアートE, (19)アスパライトロイヤルE: Stability monitoring results indicate that the possibility that the measured neostigmine methylsulfate content may fall outside the approved specifications within the shelf life (4 years 6 months or 4 years 1 month) cannot be ruled out. We have therefore decided to voluntarily recall all lots with a shelf life of 4 years 6 months or 4 years 1 month.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Recall Numbers

2-10439

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

(1)ハイデラ

Product 2

(2)マッハII

Product 3

(3)新ビターコルド

Product 4

(4)オピス錠

Product 5

(5)ヅシチン錠D

Product 6

(6)新かぜキノミン

Product 7

(7)聖心丸

Product 8

(8)赤玉ベリンはら薬

Product 9

(9)ニューリキスカット

Product 10

(10)せき

Product 11

(11)ネツトリトンプク

Product 12

(12)ノイスルピー

Product 13

(13)ブレーエン

Product 14

(14)解熱鎮痛アスナオール

Product 15

(15)チンツーサン

Product 16

(16)アスパライトE40

Product 17

(17)アイムードE40

Product 18

(18)ニューハイアートE

Product 19

(19)アスパライトロイヤルE

Product 20

(20)サーチS

Product 21

(21)サーチ5

Product 22

(22)ピタールS

Product 23

(23)サマーS

Hazard

Manufactured using quantities of additives different from those specified in the approval documents, and other issues. Reasons for recall: (1)ハイデラ, (2)マッハII, (4)オピス錠, (5)ヅシチン錠D, (8)赤玉ベリンはら薬: Because these products were manufactured using quantities of additives different from those specified in the approval documents, we have decided to voluntarily recall all lots manufactured using those quantities. (3)新ビターコルド, (9)ニューリキスカット: Because these products were manufactured using procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (6)新かぜキノミン: Because this product was manufactured using quantities of additives different from those specified in the approval documents and additives not listed in the approval documents, we have decided to voluntarily recall all lots. (7)聖心丸, (10)せき, (11)ネツトリトンプク, (12)ノイスルピー, (13)ブレーエン, (14)解熱鎮痛アスナオール, (15)チンツーサン: Because these products were manufactured using quantities of additives different from those specified in the approval documents and procedures different from the manufacturing methods specified in the approval documents, we have decided to voluntarily recall all lots. (16)アスパライトE40, (17)アイムードE40, (18)ニューハイアートE, (19)アスパライトロイヤルE: Stability monitoring results indicate that the possibility that the measured neostigmine methylsulfate content may fall outside the approved specifications within the shelf life (4 years 6 months or 4 years 1 month) cannot be ruled out. We have therefore decided to voluntarily recall all lots with a shelf life of 4 years 6 months or 4 years 1 month.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

中新薬業

Manufacturer

中新薬業株式会社

Phone

076-475-2122

Brand: 中新薬業. Contact: 中新薬業株式会社. Phone 076-475-2122.

Source & status

Source

Tier

official

Category

HEALTH

Official classification

PMDA Class II — 回収

Recall details

Recall number

2-10439

Event id

CAA-00000028677

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 26 Nov 2021. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button